Exploring ART intake scenes in a human rights-based intervention to improve adherence: A randomized controlled trial

AIDS and Behavior

Volumn 17, Issue 1, 2013, Pages 181-192

  Basso, Cáritas Relva ^a,b   Helena, Ernani Tiaraju Santa ^b,c   Caraciolo, Joselita Maria Magalhães ^a,b   Paiva, Vera ^b   Nemes, Maria Ines Battistela ^b  

^a Ref and Training Center for Sexually Transmitted Infection and Acquired Immunodeficiency Syndrome   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Adherence intervention; Antiretroviral therapy; HAART; HIV AIDS; Human rights; Psychosocial intervention; Social constructionism

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INTERVENTION STUDY; MALE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICS; VIROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMAN RIGHTS; HUMANS; INTERVENTION STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; VIRAL LOAD; YOUNG ADULT;

MLCS; MLOWN;

EID: 84872680090     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0175-4     Document Type: Article

References (61)

1. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-66.
2. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
3. Bangsberg DR. Less than 95 % adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939-41.
4. FeA Acurcio, Puig-Junoy J, Bonolo PeF, Braga Ceccato MG, Guimarães MD. Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil. Rev Esp Salud Publica. 2006;80(1):41-54.
5. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632-41.
6. Munakata J, Benner JS, Becker S, Dezii CM, Hazard EH, Tierce JC. Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus. Med Care. 2006;44(10):893-9.
7. Lamiraud K, Moatti JP. Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients. Expert Opin Pharmacother. 2006;7(2):135-43.
8. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
9. Wahl LM, Nowak MA. Adherence and drug resistance: predictions for therapy outcome. Proc Biol Sci. 2000;267(1445):835-43.
10. Nemes MIB, Beaudoin J, Conway S, Kivumbi GW, Skjelmerud A, Vogel U. Evaluation of WHO's contribution to "3 by 5": main report. Geneva: World Health Organization, 2006.
11. Bennett S, Chanfreau C. Approaches to rationing antiretroviral treatment: ethical and equity implications. Bull World Health Organ. 2005;83(7):541-7.
12. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.
13. WHO. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
14. Ministério da Saúde. Diretrizes para o fortalecimento das ações de adesão ao tratamento para pessoas que vivem com HIV e Aids. In: Coordenação Nacional de DST/Aids, editor. Brasília. Brasil: Ministério da Saúde 2008.
15. Caraciolo JMM, Santa Helena ET, Basso CR, Souza RA, Silva MH, Adão VM, et al. Intervention to enhance HAART adherence in HIV/Aids health services in the State of São Paulo, Brazil, 2007. Saude Soc. 2009;18 suppl 2:78-93.
16. Garcia R, Pondé M, Lima M, Souza AR, Stolze SM, Badaró R. Lack of effect of motivation on the adherence of HIV-positive/AIDS patients to antiretroviral treatment. Braz J Infect Dis. 2005;9(6):494-9.
17. Gupta N, Silva AC, Passos LN. The role of integrated home-based care in patient adherence to antiretroviral therapy. Rev Soc Bras Med Trop. 2005;38(3):241-5.
18. Sampaio-Sa M, Page-Shafer K, Bangsberg DR, Evans J, Dourado Mde L, Teixeira C, et al. 100 % adherence study: educational workshops versus video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav. 2008;12(Suppl 4):S54-62.
19. Berkman A, Garcia J, Munoz-Laboy M, Paiva V, Parker R. A critical analysis of the Brazilian response to HIV/AIDS: lessons for controlling and mitigating the epidemic in developing countries. Am J Public Health. 2005;95(7):1162-72.
20. Paim J, Travassos C, Almeida C, Bahia Ligia, Macinko J. The Brazilian health system: history, advances and challenges. Lancet. 2011;377(9779):1778-97.
21. Mann J, Tarantola D, editors. AIDS in the world II. New York: Oxford University Press; 1996.
22. Ayres JRCM, Paiva V, França JR I. From natural history of disease to vulnerability: changing concepts and practices in contemporary public health. In: Sommer RPaM, editor. Routledge Handbook in Global Public Health. 1 edition ed. Abingdon, Oxon: T & F Books; 2011. p. 98-107.
23. Ayres J. Access to AIDS treatment: appropriateness and correctness in the pursuit of good practice. Cad Saude Publica. 2006;22(4):705-31.
24. Gruskin S, Tarantola D. Universal Access to HIV prevention, treatment and care: assessing the inclusion of human rights in international and national strategic plans. AIDS. 2008;22(Suppl 2):S123-32.
25. Kalichman A, Diniz S. AIDS treatment in Brazil: what kind of evidence do we need? Lancet. 2009;374(969):1066.
26. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS. 2004;18(Suppl 3):S15-20.
27. Paiva V, Teixeira P, Shimma E. What is being done to improve ARV therapy in São Paulo, Brazil. XIII International AIDS Conference; Durban: Marathon Multimidia; 2000.
28. Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006;3:CD001442.
29. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285-97.
30. Nemes M, Helena E, Caraciolo J, Basso C. Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches. Cad Saude Publica. 2009;25:S392-400.
31. Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269-76.
32. Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns. 1995;26(1-3):139-44.
33. Britain. RPSoG. From compliance to concordance: toward shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain; 1997.
34. Ayres JRCM, Paiva V, França I Jr, Silva NGd, Lacerda R, Negra MD, et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. Am J Public Health. 2006;96:1001-6.
35. Paiva V, Ayres J, Grusking S. Being young and living with HIV: the double neglect of sexual citizenship. Routledge Handbook of Sexuality, Health and Rights. New York: Taylor & Francis Group; 2010. p. 422-430.
36. Paiva V, Ayres J, França I Jr. Expanding the flexibility of normative patterns in youth sexuality and prevention and care programs. In: Sexuality Research & Social Policy. Journal of NCRC Access at http://nsrc.sfsu.edu. 2004;1 Suppl 1.
37. Ayres JR. O cuidado, os modos de ser (do) humano e as práticas de saúde. Saude Soc. 2004;13(3):16-29.
38. Benzaken A, Galban Garcia E, Sardinha J, Paiva V. Community-based intervention to control STD/AIDS in the Amazon region, Brazil. Rev Saude Publica. 2007;41:118-26.
39. Paiva V, Garcia J, Rios L, Santos A, Terto V, Munõz-Laboy. Religious communities and HIV prevention: an intervention study using a human rights-based approach. Health. GP, editor. 2010.
40. Paiva V. Analysing sexual experiences through "scenes": a framework for the evaluation of sexuality education. Sex Educ. 2005;5(Suppl 4):345-58.
41. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendation for a public health approach. In: HTM/HIV, editor. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2006 rev.
42. Freire P. Pedagogy of the oppressed. 30th ed. New York: The continuum International Publishing Group Inc; 2006. p. 195.
43. Anggleton P, Parker R (Org). Routledge Handbook of Sexuality, Health and Rights. 1 ed. New York: Taylor & Francis Group; 2010.
44. Parker R, Aggleton P. Introduction. Sexuality, Culture and Health. Routledge Handbook of Sexuality, Health and Rights. 2nd edition. New York. 2007. p. 1-13.
45. Paiva V. Gendered scripts and the sexual scenes: promoting sexual subjects among Brazilians teenagers. In: Aggleton RPP, editor. Sexuality, Culture and Health. 2nd ed. New York: Taylor & Francis Group; 2007. p. 427-43.
46. Maluwa M, P' A. RG. P. HIV and AIDS-related stigma, discrimination and human rights. A critical overview. Health and Human Rights. 2002;6(1):1-18.
47. Parker RG, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13-24.
48. Garrido PB, Paiva V, do Nascimento VL, Sousa JB, Santos NJ. AIDS, stigma and unemployment: implications for health services. Rev Saude Publica. 2007;41(Suppl 2):72-9.
49. Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S103-6.
50. Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007;63(12):1115-21.
51. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59(1):56-66.
52. Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619-27.
53. Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20(9):1295-302.
54. Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA, Team NIoMHHLP. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574-80.
55. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16 Suppl 2:CD000011.
56. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23-35.
57. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:55.
58. Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS. 1999;13(7):797-804.
59. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93-108.
60. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-79.
61. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-32.